What's breaking now, across thousands of outlets.
(RTTNews) - Hyloris Pharmaceuticals SA (HYL.BR) announced that its partner AFT Pharmaceuticals Ltd. (AFT.NZ) has entered into an exclusive agreement with Mikasa Seiyaku Co Ltd. for the commercialization of Maxigesic IV in Japan.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
IPOH, Sept 28 (Bernama) -- The National Mental Health Crisis Line (HEAL 15555) has intervened in 518 behavioural crisis cases over the past four years, covering suicidal ideation and suicide attempts.
Pakistan is facing a growing shortage of essential medicines, with more than 100 life-saving drugs no longer available in the … Read More The post Pakistan Faces Shortage of Over 100 Life-Saving…
Researchers highlighted that traumatic dental injury represents a neglected condition of substantial global burden, noting that, if included among the world’s most frequent acute and chronic diseases…
The second phase will also train 800 healthcare workers and 1,150 community health promoters to improve access to specialised paediatric care in underserved areas.
IPOH: The Health Ministry has launched a national registry to provide a more comprehensive picture of suicide and fatal injury cases as part of efforts to strengthen suicide prevention.
Hospitals and other healthcare providers risk losing access to SHA systems and being barred from serving SHA beneficiaries from October 1 if they fail to complete new contracts before the expiry of…
